Processa Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Processa Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2013 to Q3 2024.
  • Processa Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 3.27M shares, a 86.7% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 3.27M -21.4M -86.7% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 2.87M -21.7M -88.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 2.86M -21.7M -88.4% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 1.29M +484K +60.4% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 24.6M +8.74M +55% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 24.5M +8.71M +55.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 24.5M +8.69M +54.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 802K -14.9M -94.9% Dec 31, 2022 10-K 2024-03-29
Q3 2022 15.9M +296K +1.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 15.8M +215K +1.38% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 15.8M +316K +2.04% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 15.7M +1.53M +10.8% Dec 31, 2021 10-K 2023-03-30
Q3 2021 15.6M +9.83M +171% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 15.6M +10.1M +183% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 15.5M +10M +183% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 14.2M +8.7M +158% Dec 31, 2020 10-K 2022-03-30
Q3 2020 5.77M -32.6M -85% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 5.51M -33.2M -85.7% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 5.49M -33.2M -85.8% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 5.49M -38.4K -0.7% Dec 31, 2019 10-K 2021-03-25
Q3 2019 38.4M -270K -0.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 38.7M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 38.7M +3.4M +9.64% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 5.53M -29.7M -84.3% Dec 31, 2018 10-K 2020-03-06
Q3 2018 38.7M +14M +56.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 38.7M +27.7M +251% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 35.3M +24.3M +220% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 35.3M +3.53M +11.1% Dec 31, 2017 10-K/A 2019-04-08
Q3 2017 24.7M +13.7M +124% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 11M 0 0% Jun 30, 2017 10-Q 2017-10-04
Q1 2017 11M -44K -0.4% Mar 31, 2017 10-Q 2017-10-04
Q4 2016 31.7M +20.7M +188% Dec 31, 2016 10-K 2018-04-16
Q3 2016 11M -253 0% Sep 30, 2016 10-Q 2017-09-08
Q2 2016 11M 0 0% Jun 30, 2016 10-Q 2017-08-30
Q1 2016 11.1M +43.8K +0.4% Mar 31, 2016 10-Q 2017-08-07
Q4 2015 11M +65K +0.59% Dec 31, 2015 10-K 2017-09-25
Q3 2015 11M +2.58M +30.6% Sep 30, 2015 10-Q 2015-12-01
Q2 2015 11M +2.73M +33% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 11M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 11M +2.87M +35.5% Dec 31, 2014 10-K 2017-06-19
Q3 2014 8.43M +388K +4.82% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 8.28M +1.25M +17.8% Jun 30, 2014 10-Q 2014-08-19
Q4 2013 8.08M Dec 31, 2013 10-K 2015-04-14
Q3 2013 8.05M Sep 30, 2013 10-Q 2013-11-08
Q2 2013 7.03M Jun 30, 2013 10-Q/A 2013-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.